This brand name is authorized in Estonia, Poland, United Kingdom
The drug LECICARBON contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Sodium dihydrogen phosphate
UNII 3980JIH2SW - SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
|
|
|
|
2
Sodium hydrogen carbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE
|
|
Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A06AX02 | Carbon dioxide producing drugs | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AX Other laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1717130 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 227059, 293733 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100453369 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
